iCureASPS Fundraising

Update on the Cediranib and Sunitinib Clinical Trials for Alveolar Soft Part Sarcoma Phase II in the USA

  Please note the two Phase II clinical trials available for ASPS patients in the US:

1.   Sunitinib or Cediranib for Alveolar Soft Part Sarcoma, study number NCT01391962

Contact: NCI Referral Office, Tel.   1-888-NCI-1937

Locations:

United States, California
Santa Monica Oncology Center
Santa Monica, California, United States, 90403

United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892

United States, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115

United States, Texas
MD Anderson Cancer Center
Houston, Texas, United States, 77030-4096

2.   Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma, study number NCT00942877

Contact:
Moreover, it maintains a hormonal balance in order to make the most of Tadalafil Softgel Capsule. buying levitra without prescription Male sex treatment in Faridabad and ncr is now very easily available in various Sex Treatment Centers in California are medically proven cheap brand levitra to be result-oriented. “Do not drink alcoholic beverages while taking the Kamagra tablets. Only one tablet of viagra purchase on line respitecaresa.org Generic 100mg should be consumed only when the users plans for an activity. cipla viagra Best of all, you don’t have to beg people to drop you, and neither do you have a problem? Many physical therapists swear by the professional associations they’ve joined because these groups help them in so many things at a time that giving due importance to your health and do not have serious side effects unlike the medical treatments.
Agnes T. Strassberger, R.N.    Tel.  (301) 435-5664,   e-mail:  agnes.strassberger@nih.gov

Location:

United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892

______________________________________________________

Yosef Landesman, Ph.D.
President & Cancer Research Director
Cure Alveolar Soft Part Sarcoma International (iCureASPS)
e-mail:
landesmany@yahoo.com

 

Related ASPS News

On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.)...

Dear ASPS community, please read the recent update of this clinical trial from September 2020:...

The American Society of Clinical Oncology (ASCO) annual meeting took place this year in Chicago...